MedTrace Logo

The Bioavailability of Mycoprotein

NCT04233411 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-01-18

No results posted yet for this study

Summary

To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.

Conditions

  • Availability of Mycoprotein

Interventions

OTHER

Mycoprotein ingestion

Sponsors & Collaborators

  • University of Exeter

    lead OTHER

Principal Investigators

  • Benjamin T Wall, PhD · University of Exeter, College of Life and Environmental Sciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-08-31
Completion
2018-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04233411 on ClinicalTrials.gov